TEAD2 and metabolic dysfunction-associated steatohepatitis: Furthermore, RQs of TEAD2 mRNA in 12-week NASH, 9-week NASH, and Broth group animals with controls showed significant increases (16, 15, and 15-fold, respectively; p < 0.01).